Neural stem/progenitor cell‐derived extracellular vesicles: A novel therapy for neurological diseases and beyond
MedComm · 2023-02 · 4 (1)
DOI: 10.1002/mco2.214 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 07.02.2023. Verfasst von Xiangyu Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Neurodegeneration and Regenerative Therapy Tongji Hospital, Tongji University School of Medicine Shanghai China. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 200 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
As bilayer lipid membrane vesicles secreted by neural stem/progenitor cells (NSCs), NSC‐derived extracellular vesicles (NSC‐EVs) have attracted growing attention for their promising potential to serve as novel therapeutic agents in treatment of neurological diseases due to their unique physicochemical characteristics and biological functions. NSC‐EVs exhibit advantages such as stable physical and chemical properties, low immunogenicity, and high penetration capacity to cross blood–brain barrier to avoid predicaments of the clinical applications of NSCs that include autoimmune responses, ethical/religious concerns, and the problematic logistics of acquiring fetal tissues. More importantly, NSC‐EVs inherit excellent neuroprotective and neuroregenerative potential and immunomodulatory capabilities from parent cells, and display outstanding therapeutic effects on mitigating behavioral alterations and pathological phenotypes of patients or animals with neurological diseases. In this review, we first comprehensively summarize the progress in functional research and application of NSC‐EVs in different neurological diseases, including neurodegenerative diseases, acute neurological diseases, dementia/cognitive dysfunction, and peripheral diseases. Next, we provide our thoughts on current limitations/concerns as well as tremendous potential of NSC‐EVs in clinical applications. Last, we discuss future directions of further investigations on NSC‐EVs and their probable applications in both basic and clinical research.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Translational Neurodegeneration and Regenerative Therapy Tongji Hospital, Tongji University School of Medicine Shanghai China.
- Center for Translational Neurodegeneration and Regenerative Therapy Yangzhi Rehabilitation Hospital, Tongji University Shanghai China.
- Shanghai Frontiers Science Center of Nanocatalytic Medicine Tongji University School of Medicine Shanghai China.
- Translational Research Institute of Brain and Brain-Like Intelligence Shanghai Fourth People's Hospital, Tongji University School of Medicine Shanghai China.
- Key Laboratory of Spine and Spinal Cord Injury Repair and Regeneration, Tongji University Ministry of Education Shanghai China.
ORCID-Profile: Xiaohuan Xia
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, X., Zhu, Y., Wang, Y., Xia, X., & Zheng, J. C. (2023). Neural stem/progenitor cell‐derived extracellular vesicles: A novel therapy for neurological diseases and beyond. MedComm, 4(1). https://doi.org/10.1002/mco2.214
Vancouver
Li X, Zhu Y, Wang Y, Xia X, Zheng JC. Neural stem/progenitor cell‐derived extracellular vesicles: A novel therapy for neurological diseases and beyond. MedComm. 2023;4(1). doi:10.1002/mco2.214
BibTeX
@article{Li2023,
author = {Li, Xiangyu and Zhu, Yingbo and Wang, Yi and Xia, Xiaohuan and Zheng, Jialin C},
title = {Neural stem/progenitor cell‐derived extracellular vesicles: A novel therapy for neurological diseases and beyond},
journal = {MedComm},
year = {2023},
volume = {4},
number = {1},
doi = {10.1002/mco2.214}
}
EUVIMED